---
title: "Bichamp Cutting Technology: Net profit in the third quarter was 17.2644 million yuan, a year-on-year increase of 48.85%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263262466.md"
description: "Bichamp Cutting Technology announced that its revenue for the third quarter was 385 million yuan, a year-on-year decrease of 15.21%; net profit was 17.2644 million yuan, a year-on-year increase of 48.85%. Revenue for the first three quarters was 1.144 billion yuan, a year-on-year decrease of 13.08%; net profit was 57.8949 million yuan, a year-on-year decrease of 12.31%"
datetime: "2025-10-29T10:30:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263262466.md)
  - [en](https://longbridge.com/en/news/263262466.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263262466.md)
generator: "portal-rs"
---

# Bichamp Cutting Technology: Net profit in the third quarter was 17.2644 million yuan, a year-on-year increase of 48.85%

Bichamp Cutting Technology announced that its revenue for the third quarter was 385 million yuan, a year-on-year decrease of 15.21%; net profit was 17.2644 million yuan, a year-on-year increase of 48.85%. Revenue for the first three quarters was 1.144 billion yuan, a year-on-year decrease of 13.08%; net profit was 57.8949 million yuan, a year-on-year decrease of 12.31%

### Related Stocks

- [002843.CN](https://longbridge.com/en/quote/002843.CN.md)

## Related News & Research

- [Why You Might Be Interested In Alivus Life Sciences Limited (NSE:ALIVUS) For Its Upcoming Dividend](https://longbridge.com/en/news/297244607.md)
- [Ayes Çelik Hasır ve Çit Sanayi Converts Shareholdings to Exchange-Traded Stock](https://longbridge.com/en/news/297056791.md)
- [CommerceWest Bank declares $0.23 dividend](https://longbridge.com/en/news/297264900.md)
- [OSE Immunotherapeutics reports 24,226,111 shares outstanding, 28,898,191 voting rights as of July 31](https://longbridge.com/en/news/297067508.md)
- [Citadel Advisors discloses net short position in GTT](https://longbridge.com/en/news/297055480.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**